AR061351A1 - Composicion de carbamato de bencimidazol - Google Patents
Composicion de carbamato de bencimidazolInfo
- Publication number
- AR061351A1 AR061351A1 ARP070102576A ARP070102576A AR061351A1 AR 061351 A1 AR061351 A1 AR 061351A1 AR P070102576 A ARP070102576 A AR P070102576A AR P070102576 A ARP070102576 A AR P070102576A AR 061351 A1 AR061351 A1 AR 061351A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- bencimidazol
- carbamate composition
- prepare
- parasites
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composicion farmacéutica para la administracion en el agua de bebida, que comprende partículas de carbamato de bencimidazol que tienen un tamano de partícula promedio eficaz inferior a 450 nm y un surfactante de tipo Tween; un método para preparar la composicion; uso de la composicion para preparar un medicamento para controlar los parásitos; y un método para proteger a un animal de una infeccion parasitaria.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81392806P | 2006-06-14 | 2006-06-14 | |
EP06115495 | 2006-06-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR061351A1 true AR061351A1 (es) | 2008-08-20 |
Family
ID=38366726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070102576A AR061351A1 (es) | 2006-06-14 | 2007-06-13 | Composicion de carbamato de bencimidazol |
Country Status (9)
Country | Link |
---|---|
US (1) | US8777134B2 (es) |
EP (1) | EP2037914B1 (es) |
JP (1) | JP5126754B2 (es) |
KR (1) | KR101403135B1 (es) |
AR (1) | AR061351A1 (es) |
CA (1) | CA2660647C (es) |
MX (1) | MX2008015764A (es) |
PL (1) | PL2037914T3 (es) |
WO (1) | WO2007144362A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7419996B2 (en) * | 2003-08-13 | 2008-09-02 | The University Of Houston | Parenteral and oral formulations of benzimidazoles |
AR061351A1 (es) | 2006-06-14 | 2008-08-20 | Intervet Int Bv | Composicion de carbamato de bencimidazol |
EP2310009B1 (en) * | 2008-07-24 | 2017-12-20 | University Of Houston | Parenteral and oral formulations of benzimidazoles |
BRPI0804639A2 (pt) * | 2008-10-23 | 2010-07-20 | Formil Veterinaria Ltda | processo para preparação de formulação de suspensão veterinária para administração de medicamento insolúvel em água, por meio de sistemas de distribuição de água e respectiva formulação de suspensão veterinária para administração de medicamento insolúvel em água |
EP2409683A1 (en) | 2010-07-06 | 2012-01-25 | KRKA, D.D., Novo Mesto | Stable aqueous formulations comprising poorly water soluble active ingredients |
US10519327B2 (en) | 2018-04-20 | 2019-12-31 | Redjak, L.L.C. | Methods and coatings for protecting surfaces from bio-fouling species |
US10829649B2 (en) | 2018-04-20 | 2020-11-10 | Redjak, L.L.C. | Methods and coatings for protecting surfaces from bio-fouling species |
US10689527B2 (en) | 2018-04-20 | 2020-06-23 | Redjak, L.L.C | Methods and coatings for protecting surfaces from bio-fouling species |
BR102020021181A2 (pt) * | 2020-10-16 | 2022-04-26 | Ipanema Industria De Produtos Veterinarios Ltda | Microssuspensão contra parasitas e método para sua obtenção |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE666795A (es) | 1964-08-04 | 1966-01-13 | ||
US3480642A (en) | 1967-03-22 | 1969-11-25 | Smithkline Corp | Process for producing 2-carbalkoxyaminobenzimidazoles |
US3657267A (en) | 1969-06-20 | 1972-04-18 | Janssen Pharmaceutica Nv | Benzimidazole carbamates |
BE793358A (fr) | 1971-12-27 | 1973-06-27 | Hoechst Ag | Nouveaux derives de 2-carbalcoxy-amino-benzimidazole presentantune activite anthelmintique et leur procede de preparation |
BE795360A (fr) | 1972-02-16 | 1973-08-13 | Merck & Co Inc | Benzimidazoles phosphoryles |
US3929821A (en) | 1972-12-29 | 1975-12-30 | Syntex Inc | 5 (6)-Benzene ring substituted benzimidazole-2-carbamate derivatives |
IN142490B (es) | 1974-05-15 | 1977-07-16 | Bayer Ag | |
US3915986A (en) | 1974-06-19 | 1975-10-28 | Smithkline Corp | Methyl 5-propylthio-2-benzimidazolecarbamate |
FR2336931A1 (fr) | 1975-12-30 | 1977-07-29 | Dick Pierre | Compositions anthelminthiques a base de benzimidazoles |
US4348406A (en) | 1980-10-20 | 1982-09-07 | Schering Corporation | Novel guanidine derivatives |
EP0093497A3 (en) * | 1982-04-30 | 1985-03-20 | Smith Kline & French Laboratories Limited | Anthelmintic treatment |
DE3247615A1 (de) | 1982-12-23 | 1984-07-05 | Hoechst Ag, 6230 Frankfurt | Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
GB9115273D0 (en) | 1991-07-15 | 1991-08-28 | Pfizer Ltd | Benzimidazole anthelmintics |
SE9103776D0 (sv) | 1991-12-19 | 1991-12-19 | Astra Ab | New compounds |
US5538989A (en) | 1993-11-10 | 1996-07-23 | Hoechst-Roussel Agri-Vet Company | Fenbendazole formulations |
EP0734258A1 (en) * | 1993-12-13 | 1996-10-02 | Michael Hilary Burke | Anthelmintic composition containing rafoxanide and fenbendazole |
IES950907A2 (en) * | 1995-12-01 | 1996-02-21 | Chanelle Chemicals Ltd | "A process" |
US6093734A (en) | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
AU3606100A (en) | 1999-02-26 | 2000-09-14 | Idexx Laboratories, Inc. | Methods for administering pharmacologically active compounds to vertebrates |
DE60012947T2 (de) | 1999-09-03 | 2005-08-25 | Janssen Pharmaceutica N.V. | Tierarzneiformulierung zur verabreichung eines wasserunlöslichen arzneistoffes an einem zieltier durch ein wasserverteilsystem |
US20030055067A1 (en) | 2001-04-03 | 2003-03-20 | Schering Corporation | Antifungal composition with enhanced bioavailability |
AU2003235708A1 (en) | 2002-01-16 | 2003-07-30 | Akzo Nobel N.V. | Polytartrate composition |
JP5227795B2 (ja) | 2005-07-28 | 2013-07-03 | インターベツト・インターナシヨナル・ベー・ベー | 抗寄生虫活性を有する新規ベンゾイミダゾール(チオ)カルバメートおよびその合成 |
AR057219A1 (es) | 2005-12-06 | 2007-11-21 | Wyeth Corp | COMPOSICION, METODO PARA EL TRATAMIENTO Y CONTROL DE UNA INFECCION ECTOPARASíTICA O INFESTACION Y PROCESO PARA LA PREPARACION DE LA COMPOSICION. |
AR061351A1 (es) | 2006-06-14 | 2008-08-20 | Intervet Int Bv | Composicion de carbamato de bencimidazol |
BRPI0804639A2 (pt) | 2008-10-23 | 2010-07-20 | Formil Veterinaria Ltda | processo para preparação de formulação de suspensão veterinária para administração de medicamento insolúvel em água, por meio de sistemas de distribuição de água e respectiva formulação de suspensão veterinária para administração de medicamento insolúvel em água |
-
2007
- 2007-06-13 AR ARP070102576A patent/AR061351A1/es not_active Application Discontinuation
- 2007-06-13 PL PL07765382T patent/PL2037914T3/pl unknown
- 2007-06-13 JP JP2009514788A patent/JP5126754B2/ja active Active
- 2007-06-13 EP EP07765382.2A patent/EP2037914B1/en active Active
- 2007-06-13 KR KR1020087031152A patent/KR101403135B1/ko active IP Right Grant
- 2007-06-13 WO PCT/EP2007/055794 patent/WO2007144362A1/en active Application Filing
- 2007-06-13 MX MX2008015764A patent/MX2008015764A/es active IP Right Grant
- 2007-06-13 CA CA2660647A patent/CA2660647C/en active Active
-
2012
- 2012-03-19 US US13/424,257 patent/US8777134B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP5126754B2 (ja) | 2013-01-23 |
MX2008015764A (es) | 2009-01-07 |
PL2037914T3 (pl) | 2014-04-30 |
CA2660647A1 (en) | 2007-12-21 |
US8777134B2 (en) | 2014-07-15 |
KR20090023622A (ko) | 2009-03-05 |
EP2037914B1 (en) | 2013-10-23 |
CA2660647C (en) | 2015-07-28 |
WO2007144362A1 (en) | 2007-12-21 |
US20120213830A1 (en) | 2012-08-23 |
JP2009539933A (ja) | 2009-11-19 |
KR101403135B1 (ko) | 2014-06-19 |
EP2037914A1 (en) | 2009-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR061351A1 (es) | Composicion de carbamato de bencimidazol | |
CO6321225A2 (es) | Particulas portadoras sólidas para mejorar la procesabilidad de un agente farmacéutico | |
CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
AR051969A1 (es) | Metodos y composiciones que usan compuestos inmunomoduladores para el tratamiento y el manejo de lesiones del sistema nervioso central | |
ECSP088560A (es) | Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido | |
AR048431A1 (es) | Formulaciones galenicas de compuestos organicos | |
AR063940A1 (es) | Formulaciones de posaconazol nanoparticulado | |
DE60316323D1 (de) | Feste pharmazeutische formulierungen mit telmisartan | |
AR054227A1 (es) | Composicion de principios activos | |
UY29005A1 (es) | Composiciones plaguicidas líquidas.- | |
NO20076613L (no) | Farmasoytiske formuleringer og anvendelse derav | |
EA201200096A1 (ru) | Фармацевтическая композиция ингибитора протеазы вируса гепатита c | |
ECSP10010224A (es) | Formulaciones líquidas de hormona luteinizante (lh). | |
PL410258A1 (pl) | Weterynaryjne doustne kompozycje przeciwpasożytnicze obejmujące działające systemowo substancje czynne, sposoby i zastosowania je obejmujące | |
AR080662A1 (es) | Forma de dosis oral solida con contenido de nanoparticulas y proceso de formulacion de la misma utilizando gelatina de pescado | |
CL2017001836A1 (es) | Una composición fertilizante y el método de su uso. | |
AR051968A1 (es) | Metodos y composiciones que utilizan inhibidores de jnk para el tratamiento y manejo de la lesion del sistema nervioso central | |
PE20100740A1 (es) | Formulacion farmaceutica de rapida disolucion que comprende clorhidrato de vardenafil trihidrato | |
AR054595A1 (es) | Formulaciones/composiciones farmaceuticas de guanfacina apropiadas para forma de administracion diaria en una unica dosis | |
AR063538A1 (es) | Tratamiento de la enfermedad de parkinson | |
CL2007001752A1 (es) | Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral. | |
BRPI0415953B8 (pt) | formulação de dosagem de liberação controlada e conjunto de formas de dosagem de liberação controlada | |
ECSP10010052A (es) | Formulaciones galenicas de alisquireno y valsartan | |
CL2007003643A1 (es) | Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas. | |
AR075180A1 (es) | Formulaciones orales solidas de una pirido-pirimidinona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |